Medicaments containing doxazosin mesylate of crystalline modification D
US6476033B1 · kind B1 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2001 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Sep 18, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drugs comprising modification D of doxazosin mesylate are described. They are suitable for treating high blood pressure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.